Palmitoyl hexapeptide-12
Cosmetic ingredientCosmetic signal peptide
Also known as: Biopeptide EL, N-Palmitoyl-val-gly-val-ala-pro-gly, Lipopeptide acetate, Lipopeptide, Biopeptide El, Palmitoyl hexapeptide 12, Palmitoyl hexapeptide-12?
Very thin human evidence
- Regulatory standing. Cosmetic ingredient, not regulated as a drug
- Animal / preclinical only. Evidence is largely animal or in-vitro
- No registered human trials. Nothing registered on ClinicalTrials.gov
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Palmitoyl hexapeptide-12, sold as Biopeptide EL, is a synthetic lipopeptide used in skin care products. It links a palmitic acid fatty chain to a short peptide sequence modeled on a repeating motif in elastin, and it is thought to act as a signaling fragment that may encourage skin cells to produce matrix proteins such as elastin and collagen.
What the evidence shows
There are no registered human clinical trials and only about two published papers, so claims about firmness or elasticity rest mainly on lab work and manufacturer data rather than independent human studies. It is regulated as a cosmetic ingredient and is not FDA-approved for any medical use.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
Sources
- PubChem compound record (CID 10212452)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.